China api cloud tool Manufacturers Factory Suppliers
-
Liraglutide (recombinant Route), Diabetes Bulk, CAS No.: 204656-20-2
Liraglutide is a prescription medicine used to treat the symptoms of Type 2 Diabetes Mellitus. Liraglutide may be used alone or with other medications.
-
Daratumumab - Multiple Myeloma (CD-38 Mab), CAS No.: 945721-28-8
As the former gene engineering research center of Huadong Medicine Group, Jiuyuan is the earliest biopharmaceutical company realizing the industrialization of gene engineering in China and is known
-
Avatrombopag Maleate- Thrombocytopenia, CAS No.: 677007-74-8
Avatrombopag maleate is a prescription medicine used to treat the symptoms of Thrombocytopenia (lack of platelets in the blood).
-
Semaglutide– Diabetes (recombinant Route),diabetes Bulk,CAS No.: 910463-68-2
Semaglutide is a prescription medicine used to treat the symptoms of Type 2 Diabetes Mellitus. Semaglutide may be used alone or with other medications.
-
Dulaglutide - Diabetes (recombinant Route), Diabetes Bulk , CAS No.: 923950-08-7
DULAGLUTIDE contains dulaglutide, a human GLP-1 receptor agonist. The molecule is a fusion protein that consists of 2 identical, disulfide-linked chains, each containing an N-terminal GLP-1
-
PegFilgrastim– A Long Lasting RhG-CSF, CAS No.: 208265-92-3,Bulk
Pegfilgrastim (pegfilgrastim) is a colony-stimulating factor, a man-made form of a protein that stimulates the growth of white blood cells, used to decrease the incidence of infection
-
Fosaprepitant Dimeglumine, CAS No.: 265121-04-8,Bulk
Fosaprepitant dimeglumine for injection is a sterile, lyophilized formulation containing fosaprepitant dimeglumine, a prodrug of aprepitant, a substance P/neurokinin-1 (NK1) receptor antagonist
-
Romosozumab - Osteoporosis, CAS: 909395-70-6
Name: Romosozumab injection . Sclerostin inhibitor. INDICATIONS: Osteoporosis
-
Recombinant Human Hyaluronidase, CAS:37326-33-3
By breaking down hyaluronic acid in skin tissue, hyaluronic can increase membrane permeability and improve the absorption and dispersion of parenterally administered fluids and drugs into tissue.
-
RhIL-11 (Oprelvekin)– A Drug To Increase Platelet Count, CAS No.: 145941-26-0, Recombinant Human Interleukin-11
Generic Name: Oprelvekin. Chemical Name: Human Interleukin-11 for Injection. The only drug approved by FDA for prevention and treatment of Chemoradiotherapy-induced thrombocytopenia..
-
Palonosetron Hydrochloride– Anti-emesis After Chemotherapy Or Radiotherapy, CAS No.: 135729-62-3
Generic Name: Palonosetron Hydrochloride injection. The quality and efficacy consistency of generic drugs were evaluated.. The second generation 5-HT3 receptor antagonist, super antagonistic, long -
-
RhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) – A New Bone Repair Material, Registered As An Implanted Medical Device, API
Chemical Name: Recombinant Human Bone Morphogenetic Protein-2. A new type bone repairing material which has biological activity..
